Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure

M. Yasuhara, M. Yamaguchi, H. Shimizu, Y. Hashimoto, N. Hama, Hiroshi Itoh, K. Nakao, R. Hori

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We developed a rat model of heart failure induced by myocardial infarction (MI) which preserves responsiveness to exogenously administered natriuretic peptide, and investigated the potentiating action of neutral endopeptidase (NEP) inhibition on the renal response to endogenous natriuretic peptide in MI rats, comparing with that in the established cardiac-failing model with arterio-venous fistula (AVF). The endogenous plasma concentration of α-rat atrial natriuretic peptide (α-rANP) in the MI rat was 6.4-fold higher than that in the normal rat, and intravenous infusion of phosphoramidon (165 nmol/min/kg), an NEP inhibitor, induced larger increases in circulating α-rANP levels and natriuresis in MI rats than in normal controls. The maximal natriuretic effect of phosphoramidon (165 nmol/min/kg) was equal to that of exogenously administered α-rANP (100 pmol/min/kg) in MI rats, whereas plasma α-rANP concentration under NEP inhibition was much lower than that after administration of α-rANP. The endogenous α-rANP levels in AVF rats were as high as those in MI rats. However, the natriuretic effect of phosphoramidon was less in AVF rats than in MI rats, which was consistent with the decreased natriuretic activity observed with administration of exogenous to α-rANP in the AVF rat. These results indicate that the natriuretic effect of NEP inhibition is dependent on elevated endogenous α-rANP levels in cardiac-failing rats, but cannot be accounted for simply in terms of the increase in circulating α-rANP levels. Endogenous natriuretic peptide-mediated natriuresis under NEP inhibition also appears to correlate with the responsiveness to the exogenously administered peptide.

Original languageEnglish
Pages (from-to)1726-1730
Number of pages5
JournalPharmaceutical Research
Volume11
Issue number12
DOIs
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Neprilysin
Natriuretic Peptides
Rats
Heart Failure
Myocardial Infarction
Natriuretic Agents
Fistula
Natriuresis
Plasmas
Protease Inhibitors
Intravenous Infusions

Keywords

  • Arterio-venous fistula
  • Atrial natriuretic peptide
  • Heart failure
  • Myocardial infarction
  • Neutral endopeptidase
  • Phosphoramidon

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure. / Yasuhara, M.; Yamaguchi, M.; Shimizu, H.; Hashimoto, Y.; Hama, N.; Itoh, Hiroshi; Nakao, K.; Hori, R.

In: Pharmaceutical Research, Vol. 11, No. 12, 1994, p. 1726-1730.

Research output: Contribution to journalArticle

Yasuhara, M, Yamaguchi, M, Shimizu, H, Hashimoto, Y, Hama, N, Itoh, H, Nakao, K & Hori, R 1994, 'Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure', Pharmaceutical Research, vol. 11, no. 12, pp. 1726-1730. https://doi.org/10.1023/A:1018907215113
Yasuhara, M. ; Yamaguchi, M. ; Shimizu, H. ; Hashimoto, Y. ; Hama, N. ; Itoh, Hiroshi ; Nakao, K. ; Hori, R. / Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure. In: Pharmaceutical Research. 1994 ; Vol. 11, No. 12. pp. 1726-1730.
@article{a238b02bc5f64ad880b0932c12f311c0,
title = "Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure",
abstract = "We developed a rat model of heart failure induced by myocardial infarction (MI) which preserves responsiveness to exogenously administered natriuretic peptide, and investigated the potentiating action of neutral endopeptidase (NEP) inhibition on the renal response to endogenous natriuretic peptide in MI rats, comparing with that in the established cardiac-failing model with arterio-venous fistula (AVF). The endogenous plasma concentration of α-rat atrial natriuretic peptide (α-rANP) in the MI rat was 6.4-fold higher than that in the normal rat, and intravenous infusion of phosphoramidon (165 nmol/min/kg), an NEP inhibitor, induced larger increases in circulating α-rANP levels and natriuresis in MI rats than in normal controls. The maximal natriuretic effect of phosphoramidon (165 nmol/min/kg) was equal to that of exogenously administered α-rANP (100 pmol/min/kg) in MI rats, whereas plasma α-rANP concentration under NEP inhibition was much lower than that after administration of α-rANP. The endogenous α-rANP levels in AVF rats were as high as those in MI rats. However, the natriuretic effect of phosphoramidon was less in AVF rats than in MI rats, which was consistent with the decreased natriuretic activity observed with administration of exogenous to α-rANP in the AVF rat. These results indicate that the natriuretic effect of NEP inhibition is dependent on elevated endogenous α-rANP levels in cardiac-failing rats, but cannot be accounted for simply in terms of the increase in circulating α-rANP levels. Endogenous natriuretic peptide-mediated natriuresis under NEP inhibition also appears to correlate with the responsiveness to the exogenously administered peptide.",
keywords = "Arterio-venous fistula, Atrial natriuretic peptide, Heart failure, Myocardial infarction, Neutral endopeptidase, Phosphoramidon",
author = "M. Yasuhara and M. Yamaguchi and H. Shimizu and Y. Hashimoto and N. Hama and Hiroshi Itoh and K. Nakao and R. Hori",
year = "1994",
doi = "10.1023/A:1018907215113",
language = "English",
volume = "11",
pages = "1726--1730",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure

AU - Yasuhara, M.

AU - Yamaguchi, M.

AU - Shimizu, H.

AU - Hashimoto, Y.

AU - Hama, N.

AU - Itoh, Hiroshi

AU - Nakao, K.

AU - Hori, R.

PY - 1994

Y1 - 1994

N2 - We developed a rat model of heart failure induced by myocardial infarction (MI) which preserves responsiveness to exogenously administered natriuretic peptide, and investigated the potentiating action of neutral endopeptidase (NEP) inhibition on the renal response to endogenous natriuretic peptide in MI rats, comparing with that in the established cardiac-failing model with arterio-venous fistula (AVF). The endogenous plasma concentration of α-rat atrial natriuretic peptide (α-rANP) in the MI rat was 6.4-fold higher than that in the normal rat, and intravenous infusion of phosphoramidon (165 nmol/min/kg), an NEP inhibitor, induced larger increases in circulating α-rANP levels and natriuresis in MI rats than in normal controls. The maximal natriuretic effect of phosphoramidon (165 nmol/min/kg) was equal to that of exogenously administered α-rANP (100 pmol/min/kg) in MI rats, whereas plasma α-rANP concentration under NEP inhibition was much lower than that after administration of α-rANP. The endogenous α-rANP levels in AVF rats were as high as those in MI rats. However, the natriuretic effect of phosphoramidon was less in AVF rats than in MI rats, which was consistent with the decreased natriuretic activity observed with administration of exogenous to α-rANP in the AVF rat. These results indicate that the natriuretic effect of NEP inhibition is dependent on elevated endogenous α-rANP levels in cardiac-failing rats, but cannot be accounted for simply in terms of the increase in circulating α-rANP levels. Endogenous natriuretic peptide-mediated natriuresis under NEP inhibition also appears to correlate with the responsiveness to the exogenously administered peptide.

AB - We developed a rat model of heart failure induced by myocardial infarction (MI) which preserves responsiveness to exogenously administered natriuretic peptide, and investigated the potentiating action of neutral endopeptidase (NEP) inhibition on the renal response to endogenous natriuretic peptide in MI rats, comparing with that in the established cardiac-failing model with arterio-venous fistula (AVF). The endogenous plasma concentration of α-rat atrial natriuretic peptide (α-rANP) in the MI rat was 6.4-fold higher than that in the normal rat, and intravenous infusion of phosphoramidon (165 nmol/min/kg), an NEP inhibitor, induced larger increases in circulating α-rANP levels and natriuresis in MI rats than in normal controls. The maximal natriuretic effect of phosphoramidon (165 nmol/min/kg) was equal to that of exogenously administered α-rANP (100 pmol/min/kg) in MI rats, whereas plasma α-rANP concentration under NEP inhibition was much lower than that after administration of α-rANP. The endogenous α-rANP levels in AVF rats were as high as those in MI rats. However, the natriuretic effect of phosphoramidon was less in AVF rats than in MI rats, which was consistent with the decreased natriuretic activity observed with administration of exogenous to α-rANP in the AVF rat. These results indicate that the natriuretic effect of NEP inhibition is dependent on elevated endogenous α-rANP levels in cardiac-failing rats, but cannot be accounted for simply in terms of the increase in circulating α-rANP levels. Endogenous natriuretic peptide-mediated natriuresis under NEP inhibition also appears to correlate with the responsiveness to the exogenously administered peptide.

KW - Arterio-venous fistula

KW - Atrial natriuretic peptide

KW - Heart failure

KW - Myocardial infarction

KW - Neutral endopeptidase

KW - Phosphoramidon

UR - http://www.scopus.com/inward/record.url?scp=0028104794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028104794&partnerID=8YFLogxK

U2 - 10.1023/A:1018907215113

DO - 10.1023/A:1018907215113

M3 - Article

C2 - 7899235

AN - SCOPUS:0028104794

VL - 11

SP - 1726

EP - 1730

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 12

ER -